INS and polycystic ovary syndrome: In recent years, several studies have suggested that orally administered myo-inositol and its isomer chiro-inositol can facilitate insulin signalling, improve insulin sensitivity and reduce blood glucose concentration in human disorders associated with insulin resistance, including type 2 diabetes, polycystic ovary syndrome and gestational diabetes34–37.